Arca
Skip to content
Tools
Tools

-gene

A gene therapy.

  • Drugs ending in -gene: 153
  • Approved somewhere: 21
  • With a US drug page: 0

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-gene
Class
Gene therapies that deliver DNA to treat disease
Sub-stems
-plasmid, -vec
Most common targets
CD19 (4), F9 (3), HBB (2), TNFRSF17 (2), MAGEA4 (1), Triglyceride (1), ARSA (1), COL7A1 (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -gene or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
Afamitresgene autoleucelApprovedMAGEA4Melanoma-associated antigen 4 binding agent
Alipogene tiparvovecApprovedTriglycerideTriglyceride hydrolytic enzyme
Atidarsagene autotemcelApprovedARSAARSA exogenous gene
Axicabtagene ciloleucelApprovedCD19B-lymphocyte antigen CD19 binding agent
Beremagene geperpavecApprovedCOL7A1Collagen alpha-1(VII) chain exogenous gene
Betibeglogene autotemcelApprovedHBBHemoglobin beta chain exogenous gene
Brexucabtagene autoleucelApprovedCD19B-lymphocyte antigen CD19 binding agent
Ciltacabtagene autoleucelApprovedTNFRSF17Tumor necrosis factor receptor superfamily member 17 binding agent
Delandistrogene moxeparvovecApprovedDMDDystrophin exogenous gene
Eladocagene exuparvovecApprovedDDCDDC exogenous gene
Elivaldogene autotemcelApprovedABCD1ABCD1 exogenous gene
Etranacogene dezaparvovecApprovedF9Coagulation factor IX exogenous protein
Exagamglogene autotemcelApprovedBCL11AB-cell lymphoma/leukemia 11A gene editing negative modulator
Fidanacogene elaparvovecApprovedF9Coagulation factor IX exogenous gene
Idecabtagene vicleucelApprovedTNFRSF17Tumor necrosis factor receptor superfamily member 17 binding agent
Lovotibeglogene autotemcelApprovedHBBHemoglobin beta chain exogenous gene
Obecabtagene autoleucelApprovedCD19B-lymphocyte antigen CD19 binding agent
Onasemnogene abeparvovecApprovedSMN1, SMN2Survival motor neuron protein exogenous gene
Talimogene laherparepvecApprovedMelanoma cellMelanoma cell disrupting agent
Valoctocogene roxaparvovecApprovedF9Coagulation factor IX exogenous protein
Voretigene neparvovecApprovedRPE65Retinoid isomerohydrolase exogenous gene
Aglatimagene besadenovecPhase 3——
Anitocabtagene autoleucelPhase 3——
Bidridistrogene xeboparvovecPhase 3——
Dabocemagene autoficelPhase 3——
Donaperminogene seltoplasmidPhase 3——
Fordadistrogene movaparvovecPhase 3——
Giroctocogene fitelparvovecPhase 3F8Coagulation factor VIII exogenous gene
Lisocabtagene maraleucelPhase 3CD19B-lymphocyte antigen CD19 binding agent
Nadofaragene firadenovecPhase 3IFNA2Interferon alpha-2 exogenous gene
Nalotimagene carmaleucelPhase 3—Cell therapy
Ofranergene obadenovecPhase 3——
Pexastimogene devacirepvecPhase 3CSF2Oncolysis - selective infection and killing of tumor cells
Prademagene zamikeracelPhase 3——
Riferminogene pecaplasmidPhase 3——
Rilimogene galvacirepvecPhase 3——
Timrepigene emparvovecPhase 3——
Velimogene aliplasmidPhase 3——
Vusolimogene oderparepvecPhase 3——
Abipapogene suvaplasmidPhase 2——
Anbalcabtagene autoleucelPhase 2——
Autogene cevumeranPhase 2—Personalised cancer vaccine
Belacabnagene franleucelPhase 2——
Besvatresgene autoleucelPhase 2——
Bizalimogene ralaplasmidPhase 2——
Cemacabtagene ansegedleucelPhase 2——
Cesnicabtagene autoleucelPhase 2——
Contusugene ladenovecPhase 2TP53Cellular tumor antigen p53 exogenous gene
Cretostimogene grenadenorepvecPhase 2——
Dalucabtagene autoleucelPhase 2——
Durcabtagene autoleucelPhase 2——
Duvalgagene otiparvovecPhase 2——
Elzocabtagene autoleucelPhase 2——
Equecabtagene autoleucelPhase 2——
Etivelcabtagene erigedleucelPhase 2——
Fencabtagene autoleucelPhase 2——
Firicabtagene autoleucelPhase 2——
Igrelimogene litadenorepvecPhase 2——
Inaticabtagene autoleucelPhase 2——
Inetagugene geperpavecPhase 2——
Inodiftagene vixteplasmidPhase 2——
Ixoberogene soroparvovecPhase 2——
Lasmecabtagene timgedleucelPhase 2——
Letetresgene autoleucelPhase 2——
Linvekinogene treniplasmidPhase 2——
Macitegtagene autoleucelPhase 2——
Mesmulogene ancovacivecPhase 2——
Nendocabtagene onogedleucelPhase 2——
Nespecabtagene autoleucelPhase 2——
Ninsipapogene sibamarepvecPhase 2——
Opilrelagene atradenorepvecPhase 2——
Osencabtagene autoleucelPhase 2——
Otekinogene vusaplasmidPhase 2——
Persicabtagene lemgedleucelPhase 2——
Plixacabtagene autoleucelPhase 2——
Pomlucabtagene autoleucelPhase 2——
Prizloncabtagene autoleucelPhase 2——
Raxorulimogene belzovacirepvecPhase 2——
Reluscovtogene ralaplasmidPhase 2——
Rememulgene arelactibacPhase 2——
Remvulimorgene autoleucelPhase 2——
Resecabtagene autoleucelPhase 2——
Ribrecabtagene autoleucelPhase 2——
Satricabtagene autoleucelPhase 2——
Senacnagene enfaleucelPhase 2——
Simoladagene autotemcelPhase 2——
Suvutresgene autoleucelPhase 2——
Tavokinogene telseplasmidPhase 2——
Tezemlimogene daxadenorepvecPhase 2——
Tinocabtagene autoleucelPhase 2——
Tipapkinogene sovacivecPhase 2——
Torulimogene lonferencelPhase 2——
Tremtelectogene empogeditemcelPhase 2——
Trovocabtagene autoleucelPhase 2——
Umitrelimorgene autodencelPhase 2——
Uzatresgene autoleucelPhase 2——
Vadacabtagene leraleucelPhase 2——
Varnimcabtagene autoleucelPhase 2——
Vispacabtagene regedleucelPhase 2——
Vocimagene amiretrorepvecPhase 2——
Volamcabtagene durzigedleucelPhase 2——
Zabilugene almadenorepvecPhase 2——
Aguracingene cadoparvovecPhase 1——
Arlocabtagene autoleucelPhase 1——
Azercabtagene zapreleucelPhase 1——
Baluretgene parvecPhase 1——
Bevufenogene nofeparvovecPhase 1——
Bomtabegagene bavoparvovecPhase 1——
Botaretigene sparoparvovecPhase 1——
Cevaretigene ritoparvovecPhase 1——
Clemidsogene lanparvovecPhase 1——
Cobnabexagene anvuparvovecPhase 1——
Cotoretigene toliparvovecPhase 1——
Detalimogene voraplasmidPhase 1——
Dirloctocogene samoparvovecPhase 1——
Doruxapapogene ralaplasmidPhase 1——
Encoberminogene rezmadenovecPhase 1——
Enekinragene inzadenovecPhase 1——
Entacingene turiparvovecPhase 1——
Esepapogene zalarnarepvecPhase 1——
Ezaladcigene resoparvovecPhase 1——
Gavocabtagene autoleucelPhase 1——
Gilavebexagene anvuparvovecPhase 1——
Labafenogene marselecobacPhase 1——
Lalikinogene sifuplasmidPhase 1——
Laruparetigene zovaparvovecPhase 1——
Marnetegragene autotemcelPhase 1——
Mozafancogene autotemcelPhase 1——
Ninsipapogene sibarnarepvecPhase 1——
Nulabeglogene autogedtemcelPhase 1——
Olvimulogene nanivacirepvecPhase 1——
Opolimogene capmilisbacPhase 1——
Orvacabtagene autoleucelPhase 1——
Pariglasgene brecaparvovecPhase 1——
Pemlimogene merolisbacPhase 1——
Quaratusugene ozeplasmidPhase 1——
Rapcabtagene autoleucelPhase 1——
Rebisufligene etisparvovecPhase 1——
Renizgamglogene autogedtemcelPhase 1——
Resamirigene bilparvovecPhase 1——
Revakinagene taroretcelPhase 1——
Rivunatpagene miziparvovecPhase 1——
Rocakinogene sifuplasmidPhase 1——
Sitocabnagene loxiveleucelPhase 1——
Vanglusagene ensiparvovecPhase 1——
Verbrinacogene setparvovecPhase 1——
Volrubigene ralaparvovecPhase 1——
Voxeralgagene autotemcelPhase 1——
Zevorcabtagene autoleucelPhase 1——
Zocaglusagene nuzaparvovecPhase 1——
Zolacabtagene autoleucelPhase 1——
Beperminogene perplasmid—METHepatocyte growth factor receptor agonist
Lutadenovec autogenePhase 2——

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.